Intrathecal tigecycline is a safe and effective treatment for central nervous system infections
Autor: | Antonio Mastroianni, Valeria Vangeli, Maria Vittoria Mauro, Filippo Urso, Roberto Manfredi, Sonia Greco |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | Encephalitis, Vol 3, Iss 3, Pp 87-93 (2023) |
Druh dokumentu: | article |
ISSN: | 2765-4559 2734-1461 |
DOI: | 10.47936/encephalitis.2023.00010 |
Popis: | Both the safety and effectiveness of intrathecal tigecycline (TGC) for treatment of infections of the central nervous system (CNS) are discussed using the clinical findings from a study of a recent patient who came to our attention, along with a literature review. Although penetration into the CNS is low (approximately 11%), intraventricular TGC could help treat patients with severe post-neurosurgical CNS infections. The use of multiple routes of TGC administration appears to be encouraging and should be considered in managing life-threatening intraventricular infections. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |